Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
BMC Vet Res ; 13(1): 364, 2017 Nov 29.
Article in English | MEDLINE | ID: mdl-29187176

ABSTRACT

BACKGROUND: The prevalence of dog erythrocyte antigen (DEA 1) in canine population is approximately 40-60%. Often data are limited to a small number of breeds and/or dogs. The aims of this study were to evaluate frequency of DEA 1 in a large population of purebred and mongrel dogs including Italian native breeds and to recognize a possible association between DEA 1 and breed, sex, and genetic and phenotypical/functional classifications of breeds. Frequencies of DEA 1 blood group collected from screened/enrolled blood donors and from healthy and sick dogs were retrospectively evaluated. The breed and the sex were recorded when available. DEA 1 blood typing was assessed by immunocromatographic test on K3EDTA blood samples. The prevalence of DEA 1 antigen was statistically related to breed, gender, Fédération Cynologique Internationale (FCI) and genotypic grouping. RESULTS: Sixty-two per cent dogs resulted DEA 1+ and 38% DEA 1-. DEA 1- was statistically associated with Dogo Argentino, Dobermann, German Shepherd, Boxer, Corso dogs, the molossian dogs, the FCI group 1, 2 and 3 and the genetic groups "working dogs" and "mastiff". DEA 1+ was statistically associated with Rottweiler, Briquet Griffon Vendéen, Bernese mountain dog, Golden Retriever, the hunting breeds, the FCI group 4, 6, 7 and 8 and the genetic groups "scent hounds" and "retrievers". No gender association was observed. CONCLUSIONS: Data obtained by this work may be clinically useful to drive blood donor enrollment and selection among different breeds.


Subject(s)
Blood Group Antigens/blood , Blood Grouping and Crossmatching/veterinary , Dogs/blood , Animals , Blood Group Antigens/classification , Blood Grouping and Crossmatching/classification , Dogs/classification , Erythrocytes/immunology , Female , Italy/epidemiology , Male , Prevalence , Retrospective Studies , Species Specificity
2.
Vet Pathol ; 50(1): 110-21, 2013 Jan.
Article in English | MEDLINE | ID: mdl-22673539

ABSTRACT

The expression of Ki67, BCL-2, and COX-2 was investigated in 53 canine cutaneous mast cell tumors (MCTs) by immunohistochemistry and quantitative real time polymerase chain reaction (qPCR) to evaluate their prognostic significance and the association with the histologic grading and the mitotic index (MI). MCTs were graded according to the Patnaik grading system and the novel 2-tier grading system proposed by Kiupel. The numbers of mitotic figures/10 high-power fields (MI) were counted. Both grading systems were significantly associated with prognosis. The Patnaik grading was of limited prognostic value for grade 2 MCTs, with 23% being associated with mortality. The concordance among pathologists was strongly improved by the application of the 2-tier grading system, and 71% of high-grade MCTs were associated with a high mortality rate. MI and Ki67 protein expression were significantly associated with grading and survival. No significant association between BCL-2 protein expression and either grading system or health status was observed. BCL-2 mRNA expression was significantly higher in grade 2 than in grade 1 MCTs, while no statistically significant differences were detected between low- and high-grade MCTs. The increased BCL-2 mRNA level was significantly associated with increased mortality rate. The COX-2 protein expression was detected in 78% of the MCTs investigated. However, neither association with the tumor grade nor with the health status was observed. COX-2 mRNA was significantly up-regulated in MCTs compared to surgical margins and control skin tissue, but it was neither associated with tumor grade nor with survival.


Subject(s)
Biomarkers, Tumor/genetics , Dog Diseases/pathology , Mast-Cell Sarcoma/veterinary , Mastocytosis, Cutaneous/veterinary , Skin Neoplasms/veterinary , Animals , Biomarkers, Tumor/metabolism , Cyclooxygenase 2/genetics , Cyclooxygenase 2/metabolism , Dog Diseases/metabolism , Dogs , Female , Follow-Up Studies , Gene Expression Regulation, Neoplastic , Immunohistochemistry/veterinary , Ki-67 Antigen/genetics , Ki-67 Antigen/metabolism , Male , Mast Cells/metabolism , Mast Cells/pathology , Mast-Cell Sarcoma/metabolism , Mast-Cell Sarcoma/pathology , Mastocytosis, Cutaneous/metabolism , Mastocytosis, Cutaneous/pathology , Mitotic Index , Neoplasm Grading/veterinary , Prognosis , Prospective Studies , Proto-Oncogene Proteins c-bcl-2/genetics , Proto-Oncogene Proteins c-bcl-2/metabolism , Skin/metabolism , Skin/pathology , Skin Neoplasms/metabolism , Skin Neoplasms/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...